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Carcinoma of the ampulla of Vater is a rare gastrointestinal tumor. Additionally, cutaneous metastasis
from such an internal malignancy is also uncommon. We reported the case of a 55-year-old man afﬂicted
with ampullary carcinoma with cutaneous metastasis. The patient did not undergo the standardWhipple
procedure but received chemotherapy due to apparent left neck lymph node metastasis noted by initial
PET/CT imaging. The skin metastasis presented as a left neck inﬁltrating purpuric lesion, which was
conﬁrmed by skin biopsy approximately one year after the patient's disease was ﬁrst diagnosed.
Thereafter, the patient received further chemotherapy pursuant to his course of medical management.
Skin metastasis usually represents a poor patient prognosis. In these cases, treatment of cutaneous
metastasis typically includes systemic chemotherapy and local management such as radiation therapy or
tumor excision. And when choosing a chemotherapy regimen for the ampullary cancer, the histological
subtypes (intestinal or pancreatobiliary) should be comprehensively considered. In our review of the
literature, the intestinal type seems to have less distant lymph node metastasis, advanced local invasion,
as well as recurrence than pancreatobiliary type of ampullary cancer.
Copyright © 2016, The Chinese Oncology Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
When carcinoma of the ampulla of Vater is diagnosed, it is
generally recognized to be a rarely occurring tumor. The overall
incidence rate of the ampulla of Vater cancer was around 0.49 per
100,000 individuals in the United States, and represents only
0.2e0.5% of all gastrointestinal malignancies.1 Cutaneous metas-
tasis from internal malignancy is also uncommon, and estimated to
represent around 0.7%e9% of all patients with internal cancers.2
Lookingbill et al found that only 367 (5%) of 7316 oncology pa-
tients developed cutaneous metastasis in the tumor registry as
noted in the Milton S. Hershey Medical Center (Hershey, PA, USA).
Of that ﬁnal 367 patients, 59 (0.8%) had skin involvement as their
ﬁrst sign of undiagnosed cancer. Breast cancer was the most
commonly reported primary cancer involving skin (64.6%). Rosen
and Schwartz describe neoplasm of the breast, colon, kidney, lung
and ovary relatively likely to have cutaneous metastasis.3 Abdomen
and chest were the most reported sites of skin metastasis.nd Oncology, Department of
ospital, College of Medicine,
d, Tainan 704, Taiwan.
).
ncology Society.
Society. Production and hosting byIn a Taiwanese report, Hu et al found 124 cases (1.02%) with
cutaneous metastases from 12,146 patients with internal ma-
lignancies at Kaohsiung Medical University Hospital (Kaoh-
siung, Taiwan). The rate of skin metastasis was highest in patient
with breast cancer (2.42%), followed by cancer of the lung
(1.78%), oral mucosa (1.75%), colorectum (0.81%), stomach
(0.80%) and esophagus (0.74%).2 Compared to Caucasians, the
overall rate of cutaneous metastasis appears to be lower in
Taiwanese patient.
Here, we have presented a case of progressive ampullary cancer
with cutaneous metastasis. Generally, pancreaticoduodenectomy
(Whipple procedure) is the standard treatment for ampullary and
periampullary adenocarcinoma.4 If metastatic disease is noted,
chemotherapy schemes generally recommended for pancreatic
cancer or intestinal malignancymay be considered according to the
histological type.52. Case report
In February 2012, a 55-year-old man without previous systemic
disease suffered from abdominal pain radiating to the back, and
yellowish skin color. Ampulla of Vater cancer, cT2N1M1, cstage IV,
with local and left neck lymph node metastasis were formally
diagnosed by esophagogastroduodenoscopic biopsy, magneticElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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sion tomography and computerized tomography (PET/CT)
(Fig. 1AeC). Plastic and metallic biliary stents were placed forFig. 1. (AeB) A low signal intensity soft tissue mass (arrow) in the ampulla of Vater
with dilatation of common bile duct as seen on MRCP. (C) P PET/CT showed FDG uptake
metastatic lymph nodes over left neck (arrow).obstructive jaundice. Due to the patient's metastatic disease,
chemotherapy with high-dose ﬂuorouracil was started. However,
severe vomiting was noted after the ﬁrst chemotherapy treatment.
Therefore, the chemotherapy regimen was shifted to gemcitabine
plus oxaliplatin. The patient's diseasewas deemed stabilized after 6
cycles of therapy, and he received uracil/tegafur (UFUR) as main-
tenance therapy.
In February 2013, a left neck inﬁltrating purpuric lesion around a
previous surgical scar (lymph node biopsy) with mild pain was
noted. A subsequent skin biopsy revealed metastatic adenocarci-
noma, compatible with ampulla of Vater primary, thereby con-
ﬁrming disease progression with skin metastasis. Consequently,
chemotherapy with gemcitabine, oxaliplatin plus UFUR and local
radiation therapy were administered. However, the lesion pro-
gressed with local itching, and chemotherapy with gemcitabine,
oxaliplatin plus cetuximab was prescribed from Nov. 2013 to Feb.
2014. Unfortunately, the disease continued to progress and
extended to his left chest wall, ﬂank and back (Fig. 2AeB), so he
received palliative chemotherapy with docetaxel, followed by
cisplatin plus high-dose ﬂuorouracil and FOLFIRI (last cycle on June
17 2015). Palliative radiation therapy for skin and lymph node
metastasis was also performed. Gram negative bacteremia and
neutropenic fever were noted after recent chemotherapy. After
further discussion with the patient about reasonable options, the
patient opted to receive palliative care due to poor response to
chemotherapy as well as multiple comorbidities. Presently, he re-
mains under outpatient follow-up for palliative care.
3. Discussion
Cutaneous metastases can occur due to direct invasion of the
tumor to the surrounding tissue, by hematogenous spread, or
through lymphatic drainage. Particular sites of metastasis are seen
in speciﬁc primary malignancies, but the pathogenesis is still un-
clear. It has been observed that skin metastasis is a poor prognostic
feature. Some reports showed that skin metastasis from breast
cancer had a median survival of 31e42 months, yet patient survival
was less than 6 months among those from other primary cancers.3
According to our search of the literature, there have been only
two cases of cutaneous metastasis from ampullary cancer previ-
ously reported.6,7 The ampulla of Vater is a vital structure traversed
by important ducts and surrounded by the pancreas and duo-
denum. Preoperative staging may include such imaging and diag-
nostic tools as necessary, including extracorporeal ultrasonography
(US), CT, MRCP, esophagogastroduodenoscopic biopsy, endoscopic
US (EUS), and endoscopic retrograde cholangiopancreatography
(ERCP). For non-metastatic disease, pancreaticoduodenectomy
(Whipple procedure) is the gold standard treatment. Local resec-
tion or endoscopic papillectomy are also recognized as treatments
of choice for selected early stage cases.5 Recent studies revealed
that adequate regional lymph node dissection provided a survival
beneﬁt for T1 stage ampullary cancer (hazard ratio 0.19), compared
with local resection/ampullectomy without regional lymphade-
nectomy.8,9 Our patient was diagnosed with ampullary cancer with
distant lymph node metastasis by PET/CT, so he did not undergo
surgical intervention but instead received biliary stenting by ERCP
followed by chemotherapy.
Ampullary cancermay arise either from the intestinal epithelium
or the epithelium covering the pancreatobiliary ducts. Ninety
percent of all ampullary malignancies are adenocarcinoma, which
consist of two main histological subtypes: intestinal and pan-
creatobiliary.1 The two histological subtypes tend to have different
clinical characteristics. The incidence of histological lymph node
metastasis is much higher in cases of the pancreatobiliary type than
in those of the intestinal type (50.0% versus 23.8%). Pancreatobiliary
Fig. 2. (AeB) The skin metastasis manifested as erythematous to violaceous, bizarre
shape, inﬁltrating lesions over left chest and back areas.
Fig. 3. (A) Skin biopsy (100x) of the purpuric inﬁltrating plaques reveals many mucin
abundant atypical glandular structures with cuboidal endothelial cells (arrow), which
is compatible with metastatic adenocarcinoma from ampulla of Vater. (BeC). Immu-
nohistochemical stain of skin biopsy (100x) was positive for cytokeratin 7 (3B, arrow)
and negative for cytokeratin 20 (3C), compatible with pancreatobiliary subtype.
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recurrence (5-year disease free survival rate 47.8% versus 73.1%).10
Our patient's pathology was pancreatobiliary type, and distant
lymph node metastasis was noted at diagnosis. The immunohisto-
chemical stain of skin biopsy from cutaneous metastasis was posi-
tive for cytokeratin 7 (CK7) and negative for cytokeratin 20 (CK20)
(Fig. 3AeC), which was also compatible with pancreatobiliary origin
instead of intestinal type (usually CK20(þ) and CK7()).11Effective medical management of cutaneous metastasis arising
from internal malignancy is usually difﬁcult. Systemic chemo-
therapy and local excision or radiation therapy may be considered.
As for metastatic ampulla of Vater cancer, the more recent histo-
logical differentiation in intestinal and pancreatobiliary subtype
may inﬂuence the choice of regimen; whereas duodenal cancers
would routinely be treated like colon cancer, pancreatic cancer is
usually treated by systemic chemotherapy with a gemcitabine-
based regimen.5 Our patient suffered from local pain as the initial
symptom of skin metastasis, and itching sensation was noted with
disease progression. No obvious sensory loss or paresthesia was
I.-T. Liu, C.-J. Yen / Journal of Cancer Research and Practice 3 (2016) 54e57 57mentioned. Although several courses of systemic chemotherapy
and local radiation therapy were given, his skin metastasis showed
poor response to our management, and local pain and pruritus
were still noted.
In conclusion, internal malignancy with cutaneous metastasis is
not so common and represents poor prognosis. We reported a rare
case of ampulla of Vater cancer with skin metastasis. Ampullary
cancer with intestinal subtype seems to be less aggressive and have
better treatment response than pancreatobiliary subtype. Therefore,
immunohistochemical staining should be done at ﬁrst to distinguish
these two subtypes, which may help us to predict the patient's
outcome as well as to choose the better chemotherapy regimen.
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